BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34869637)

  • 1. Visceral Adiposity Index Plays an Important Role in Prognostic Prediction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Front Cardiovasc Med; 2021; 8():735637. PubMed ID: 34869637
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    Liu C; Zhao Q; Ma X; Cheng Y; Sun Y; Zhang D; Liu X; Zhou Y
    Cardiovasc Diabetol; 2022 Jan; 21(1):11. PubMed ID: 35045846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention.
    Liu C; Liu X; Ma X; Cheng Y; Sun Y; Zhang D; Zhao Q; Zhou Y
    Diabetol Metab Syndr; 2022 Oct; 14(1):145. PubMed ID: 36203208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of geriatric nutritional risk index on prognosis of patients with non-ST-segment elevation acute coronary syndrome: Results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1685-1696. PubMed ID: 32641219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
    Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
    Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X; Sun Y; Cheng Y; Shen H; Gao F; Qi J; Yang L; Wang Z; Shi D; Liu Y; Liu X; Zhou Y
    Lipids Health Dis; 2020 Nov; 19(1):240. PubMed ID: 33198752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral Adiposity Index Score is the Better Predictor of Clinical and Coronary Angiographic Severity Assessment than Other Adiposity Indices in Patients with Acute Coronary Syndrome.
    Biswas E; Choudhury AK; Amin MR; Khalequzzaman M; Chowdhury S; Kabir FI; Sakib MM; Mahabub EE; Singha CK
    Mymensingh Med J; 2019 Apr; 28(2):382-388. PubMed ID: 31086155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Lipids Health Dis; 2020 Jul; 19(1):179. PubMed ID: 32736631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Lipids Health Dis; 2011 May; 10():88. PubMed ID: 21619588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.
    Gargiulo G; Carrara G; Frigoli E; Leonardi S; Vranckx P; Campo G; Varbella F; Calabrò P; Zaro T; Bartolini D; Briguori C; Andò G; Ferrario M; Limbruno U; Colangelo S; Sganzerla P; Russo F; Nazzaro MS; Esposito G; Ferrante G; Santarelli A; Sardella G; Windecker S; Valgimigli M
    J Am Coll Cardiol; 2019 Feb; 73(7):758-774. PubMed ID: 30784669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome.
    Li C; Fan H; Liu Y; Zeng L; Chen P; Duan C; Liang H; He P
    Ann Transl Med; 2021 Nov; 9(21):1627. PubMed ID: 34926671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent association between the visceral adiposity index and microalbuminuria in patients with newly diagnosed type 2 diabetes.
    Wen J; Yuan H
    Diabetes Metab Res Rev; 2020 Jan; 36(1):e3198. PubMed ID: 31228226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome.
    Liu C; Zhao Q; Zhao Z; Ma X; Xia Y; Sun Y; Zhang D; Liu X; Zhou Y
    Front Endocrinol (Lausanne); 2022; 13():1033354. PubMed ID: 36452320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.